iAward

Sanofi iAwards initiative is a multi-institutional partnership program designed to support collaborations with academic investigators to accelerate innovative early stage, disease-relevant research towards the clinic. With this program, Sanofi aims to fund cutting-edge translational research that can contribute to our early-stage pipeline and ultimately benefit patients.

 

Welcome to the iAwards!

 

 

Welcome to the iAwards! This initiative is designed to accelerate external innovation by supporting bold, transformative early-stage research that enhances the R&D pipeline.  


Through the iAwards, Sanofi aims to launch one-year projects that lay the foundation for sustained, mutually beneficial partnerships—driving innovation and impact in healthcare R&D. 

 

Sanofi is a global pharmaceutical company dedicated to advancing healthcare access and improving outcomes for patients across the continuum of care.

 

Know more

Why Apply?

 

Award Benefits

 

¥1,060,000 in China / €120.000 in Europe / $150,000 USD in North America 
 
Dedicated Sanofi scientific mentorship
 
Support for 1-year research plan with shared expertise and guidance
 
Privileged access to collaboration opportunities beyond the initial project 
 

Program Objectives

Embrace Innovation

Identify high-potential projects from leading academic institutions and medical centers and foster the development of novel translational technologies. 

De-risk High-Value Concepts

Provide early-stage support to ambitious ideas with strong potential to transform R&D, reducing risk and enabling progress. 

Cultivate Strategic Partnerships

Build meaningful relationships with innovators that can evolve into long-term collaborations. 

Contact Information

Should you have any further question regarding the initiative, application, selection process, scope, etc. please contact: 

and put your region in the email header (AS, EU, NA). 

Questions will be directed to respective region leads, based on the location of the applicant:

For Asian (AS) Applicants: Yao Xie and Yang Bai
    For European (EU) Applicants: Antonio Almario
For (NA) Applicants: Luke Hanlin

Participate